Health - Latest News Search Engine - Global and Local Breaking News

Health

Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research

New test offerings target solid tumors and hematologic malignancies Enhanced biopharma services support accelerated clinical trials and companion diag...

Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research

From FDM to SLA and SLS: Vision Miner Delivers Nearly a Decade of Expertise as a One-Stop Additive Manufacturing Solution Provider for Industrial Appl...

COSTA MESA, Calif., May 30, 2025 /PRNewswire/ -- Vision Miner today emphasized its role as a leading one-stop additive manufacturing (AM) solution pro...

From FDM to SLA and SLS: Vision Miner Delivers Nearly a Decade of Expertise as a One-Stop Additive Manufacturing Solution Provider for Industrial Applications

BioLineRx Announces New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-Line Pancreatic Cancer (PDAC) to be Presented at ASC...

- 4 of 11 PDAC patients in the pilot phase remained progression free at over one year - Poster presentation on Saturday, May 31st TEL AVIV, Israel, Ma...

BioLineRx Announces New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-Line Pancreatic Cancer (PDAC) to be Presented at ASCO 2025 Annual Meeting

Weekly Recap: 14 Health Press Releases You Need to See

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including AI-powered dream reconstruction, veterans' health at ...

Weekly Recap: 14 Health Press Releases You Need to See

Isotopia and Cardirad Announce Launch of Isoprotrace® in Sweden and Denmark, Expanding Access to Advanced Prostate Cancer Imaging

PETAH TIKVA, Israel, May 30, 2025 /PRNewswire/ -- Isotopia Molecular Imaging, in partnership with Cardirad , proudly announces the launch of Isoprotra...

Isotopia and Cardirad Announce Launch of Isoprotrace® in Sweden and Denmark, Expanding Access to Advanced Prostate Cancer Imaging

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., May 30, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to ...

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference

BOSTON, May 30, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside...

Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Disposable vapes ban unlikely to reduce appeal, says campaigner

They warn some reusable vapes have "identical" packaging to single-use ones and are sold at the same price.

Disposable vapes ban unlikely to reduce appeal, says campaigner

GC Biopharma's Phase 3 Clinical Trial Results for Hunterase Published in SCIE-Indexed Journal

YONGIN, South Korea, May 30, 2025 /PRNewswire/ -- GC Biopharma, a South Korean pharmaceutical company, announced that the Phase 3 clinical trial resul...

GC Biopharma's Phase 3 Clinical Trial Results for Hunterase Published in SCIE-Indexed Journal

Highlights of ESHG | Rapid AI Karyotype Total Solution From China Makes a Big Splash

MILAN, Italy, May 30, 2025 /PRNewswire/ -- From May 24 to 27, 2025, the annual conference of the European Society of Human Genetics (ESHG) 2025 held s...

Highlights of ESHG | Rapid AI Karyotype Total Solution From China Makes a Big Splash

Medicilon besteht FDA-Inspektion und stärkt globale F&E-Exzellenz

BOSTON, 30. Mai 2025 /PRNewswire/ -- Am 20. Mai gab Medicilon Preclinical Research (Shanghai) LLC („Medicilon") bekannt, dass es eine Inspektion vor O...

Medicilon besteht FDA-Inspektion und stärkt globale F&E-Exzellenz

Medicilon absolvuje kontrolu FDA a upevňuje tak svoju globálnu excelentnosť v oblasti výskumu a vývoja

BOSTON, 30. máj 2025 /PRNewswire/ – Dňa 20. mája spoločnosť Medicilon Preclinical Research (Shanghai) LLC („Medicilon") oznámila, že úspešne absolvova...

Medicilon absolvuje kontrolu FDA a upevňuje tak svoju globálnu excelentnosť v oblasti výskumu a vývoja

Medicilon supera la inspección de la FDA, reforzando su excelencia global en I+D

BOSTON, 30 de mayo, 2025 /PRNewswire/ -- El 20 de mayo, Medicilon Preclinical Research (Shanghai) LLC ("Medicilon") anunció que superó con éxito una i...

Medicilon supera la inspección de la FDA, reforzando su excelencia global en I+D

Medicilon passe avec succès l'inspection de la FDA, réaffirmant ainsi son excellence mondiale en matière de R&D

BOSTON, 30 mai 2025 /PRNewswire/ -- Le 20 mai, Medicilon Preclinical Research (Shanghai) LLC (« Medicilon ») a annoncé qu'elle avait passé avec succès...

Medicilon passe avec succès l'inspection de la FDA, réaffirmant ainsi son excellence mondiale en matière de R&D

Medicilon z pozytywnym wynikiem kontroli FDA, umacniając doskonałość badawczo-rozwojową na skalę globalną

BOSTON, 30 maja 2025 r. /PRNewswire/ -- W dniu 20 maja, spółka Medicilon Preclinical Research (Shanghai) LLC ("Medicilon") ogłosiła pomyślne zakończen...

Medicilon z pozytywnym wynikiem kontroli FDA, umacniając doskonałość badawczo-rozwojową na skalę globalną